Purpose: Evaluating the status of disease progression is critical for planning a therapeutic strategy for esophageal cancer. In this regard, F-18 fluorodeoxyglucose-labeled positron emission tomography (PET) is one of the most useful diagnostic modalities. However, there is room to improve its diagnostic performance, such as distinguishing lymph nodal metastases from false positives. In this study, we examined the diagnostic accuracy of fluorodeoxyglucose PET accompanied by computed tomography imaging (PET/CT) to detect regional lymph nodal metastasis from esophageal squamous cell carcinoma (ESCC). Methods: A total of 102 patients diagnosed as ESCC were subjected to this study. These patients had a preoperative PET/CT examination to evaluate the existence of metastasis. The values of maximum standardized uptake value (SUVmax) in primary tumors and in metastasized lymph nodes were measured to analyze their relationship with various clinicopathologic characteristics including the status of tumor cell proliferation, which was assessed by immunohistochemistry for Ki-67. Results: The SUV max of the primary tumor was positively correlated with tumor size and vessel invasion, and was positively related with the SUV max of lymph nodal metastasis, especially in cases of poorly differentiated ESCC. The SUV max of metastasized lymph nodes was higher in larger-sized metastasized lymph nodes, whereas the Ki-labeling index of lymph nodal metastasis was positively related with the SUVmax per unit area (SUV max /mm 2 ). The diagnostic accuracy of PET/CT (87.3%) was higher than that of conventional CT scans (78.4%).
squamous cell carcinoma and adenocarcinoma. Adenocarcinoma is found more in European countries and North America than elsewhere, and exhibits various distributions among different races and ethnicities. 1 Development of adenocarcinoma is considered to have a deep relationship with Barrett esophagus and gastroesophageal reflux disease. 2, 3 On the other hand, more squamous cell carcinoma is found in Asian countries including Japan. It is associated with alcohol and tobacco, and is found more in Japan, China, and Korea than in other Asian countries. It was reported that people missing the gene ALDH2 are at higher risk for this cancer. 4 Compared with other digestive carcinomas, lymph nodal metastasis tends to be found at earlier stages with esophageal carcinoma, and the severity of the lymph nodal metastasis greatly affects the prognosis. 5 Classically, radiographic determination of lymph nodal metastasis has focused on detecting a certain size of lymph nodes by a conventional computed tomography (CT) scan. Other than radiographic methods, endoscopic ultrasound is another effective examination for the detection of lymph nodal metastases from esophageal cancer with various ranges of sensitivity and specificity. 6, 7 However, both of those diagnostic capabilities have some limitations detecting microscopic metastasis and distinguishing metastasized lymph nodes from an inflammatory enlargement of the lymph nodes. 8 -10 Esophageal cancer cases that are accompanied with positive lymph nodal metastasis often require a multidisciplinary treatment including surgical treatment and systemic chemotherapy. 11 An accurate diagnosis of lymph nodal metastasis is important when deciding on the appropriate treatment, although there is currently no worldwide standardized system for the diagnosis of lymph node metastases. 12 F-18 fluorodeoxyglucose (FDG)-labeled positron emission tomography (PET) has emerged in recent years as one of the most useful examinations for lymph node metastases and distant metastases. Especially for distant metastasis diagnosis, FDG PET has been shown to have high diagnostic performance. 13 PET examinations have been shown to have a significantly higher specificity and accuracy compared with the conventional CT examinations for lymph nodal metastasis diagnosis, and particularly the specificity is reported to be higher. 6, 14 On the other hand, it sometimes difficult to diagnose an inflamed and enlarged lymph node even with an FDG PET examination, just as it is difficult for CT examinations and FDG PET examinations to detect a microscopic metastasis. 15 Furthermore, there is a report that the specificity of FDG PET for diagnosing lymph nodal metastasis around the esophagus tends to be low. In more recent years, FDG PET has been extensively combined with CT images to help improve the diagnostic accuracy for lymph nodal metastasis, and its utility has been reported upon. 16 A remaining obstacle to the recognition of FDG PET in combination with CT scan (PET/CT) as the best preoperative examination for an assess-ment of esophageal cancer progression is whether the preoperative diagnosis by PET/CT is compatible to the results of the postoperative pathologic assessment for patients who had surgeries.
There is a previous report examining the relationship between tumor cell proliferation, lymph nodal metastasis, and the progress of tumors. 17 However, in this study, we further try to clarify correlations of maximum standardized uptake value (SUV max ) with the primary tumor, various factors of lymph nodal metastasis, and tumor cell proliferation using PET/CT. The values of SUV max in the primary tumor were analyzed with the following 4 clinicopathologic factors: (1) differentiation, (2) depth of tumor invasion, (3) lymphatic invasion, and (4) venous invasion. For lymph nodal metastasis, the correlation of the SUV max of the lymph node with the various factors of the primary tumor was studied, and the correlation with the tumor volume of the lymph nodal metastasis was also studied. Furthermore, the SUV max per unit area of the lymph nodal metastasis was calculated in each case and examined with the Ki-labeling index (Ki LI). Finally, the diagnostic accuracies of conventional CT scans and PET/CT were compared.
PATIENTS AND METHODS

Patients and Lymph Nodes
This was a retrospective study in which we selected 102 consecutive subjects (patients with uncontrollable diabetes were excluded) who had surgery between June 2006 and January 2009 for esophageal cancer at Okayama University Hospital. Before surgery, all of them received our routine examinations including FDG PET at the same medical facility (Okayama Diagnostic Imaging Center, Okayama, Japan) and a conventional CT scan (Okayama University Hospital) to obtain a preoperative assessment of primary tumor progression and lymph nodal metastasis. For the lymph nodal metastasis examination, 114 stations of lymph nodes that were dissected at the time of the esophagectomy were examined. We have obtained comprehensive informed consent from all of the patients who had operations at Okayama University Hospital in regard to the usage of all examination data including radiographic pictures and pathologic investigation for research purposes.
A total of 102 patients had an esophagectomy to treat thoracic esophageal cancer. All of the cases had squamous cell carcinoma. There were 90 male and 12 female cases. The average age of the 102 cases was 64.9 Ϯ 8.96 years old. We classified the cases into groups based on several clinicopathological criteria (histology, depth of tumor invasion, lymphatic vessel invasion, and venous vessel invasion) according to the Japanese Classification of Esophageal Cancer (10th edition). 18
PET/CT Imaging
The PET/CT was taken at the recommended standard setting with a PET/CT Scanner Biograph LSO/Sensation 16 (Siemens, Munchen, Germany) at the Okayama Diagnostic Imaging Center (Figs. 1A, B ). After at least 5 hours fasting, the patients had an intravenous injection of 0.1 mCi (3.7 MBq)/kg of FDG. The FDG PET images were obtained 90 minutes after the FDG injection. The FDG PET images were reconstructed with an ordered-subset expectation maximization iterative reconstruction algorithm. The technical parameters for the 16-detector row helical CT included a section thickness of 3 mm. Areas of focally increased glucose uptake were evaluated by standardized uptake values (SUVs). The maximum SUV (SUV max ) for each site was calculated by the conventional formula normalized for body weight.
Diagnostic Criteria of Lymph Nodal Metastasis, Tumor Volume, and Immunohistologic Examinations
The criterion of positive lymph nodal metastasis for PET was determined to be more than 2.5 SUV max . The diagnostic criterion of a positive lymph nodal metastasis for CT was determined to be if the major axis of the lymph node was longer than 5 mm, in accordance with reports on improving the diagnostic accuracy of lymph nodal metastasis by radiographic assessment. 8, 19 To examine the tumor volume of the lymph nodal metastasis and SUV max , the tumor site of the maximum cut surface of the lymph nodal metastasis was used. 20 The Ki-67 labeling index was used to examine the tumor-cell proliferation of the lymph nodal metastasis. When examining the correlation between the tumor cell proliferation of the lymph nodal metastasis and the SUV max , a significant positive correlation was found between the tumor volume of the lymph nodal metastasis and the SUV max . Therefore, the SUV max per unit tumor volume was used for the examination to correct for the effect caused by the tumor volume. This means that the correlation between Ki LI and SUV max /mm 2 was examined. For the correlation analysis, Spearman rank correlation coefficient was used.
Immunohistochemistry
In addition to H-E staining (Fig. 1C) , immunostaining was performed on the antibodies for Ki-67 (monoclonal mouse antibody MIB-1, 1: 100 dilution). The following staining reagents were used: for the primary antibody, Monoclonal Antihuman mouse Ki-67 antigen (DAKO, Denmark) was used. The clone; serial number M7240 MIB-1 (DAKO, Denmark). The secondary antibody; envisionϩ, mouse/HRP (DAKO, Denmark) serial number K4007 1100 test. The antibody dilution was S3022 (DAKO, Denmark), and the liquid reagents were adjusted. Chromogenic substrate; k3468 (DAKO, Denmark) diaminobenzidine (DAB) ϩ, liquid.
The Polymer method was used for staining. First, deparaffinization and hydrophilic treatment were done, and then antigen retrieval and endogenous peroxidase blocking were done. After that, the specimen was reacted with primary antibody, enzyme labeling polymer as reagent and chromogenic substrate in that order. Finally, counterstaining and mounting were done. The Ki-67 labeling index (described as Ki LI) was measured as described previously. 21 Briefly, Ki LI was calculated for each section based on approximately 1000 carcinoma cell nuclei. Positive staining corresponds to a dark brown color (Fig. 1D ).
Statistical Analysis
We divided the cases into 2 groups (eg, venous invasion ϩ and Ϫ) based on the status of each clinicopathologic factor and statistically compared their average values of SUV max by the Student t test. An analysis of variance was used for the correlation analysis of the SUV max of primary tumors and the SUV max of the lymph nodal metastasis, for the correlation analysis of the tumor volume of the lymph nodal metastasis and the SUV max of lymph nodal metastasis and for the correlation analysis of the SUV max of lymph nodal metastasis and Ki LI. The correlations were evaluated using the Pearson product-moment correlation coefficient. The correlation between the SUV max per unit area of the lymph nodal metastasis and Ki LI was examined using Spearman rank correlation coefficient. All of the tests and examinations that had P Ͻ 0.05 were determined to have a significant difference. JMP 8.0 (SAS Institute, Inc.) was used for the statistical analysis.
RESULTS
Subject Cases
All of the cases were sorted into 2 groups of well to moderately differentiated (68 cases) or poorly differentiated (34 cases). When the cases were sorted according to the depth of tumor invasion, T1, T2, T3, and T4 had 39, 7, 53, and 3 cases, respectively, indicating that the majority was progressive cancer cases that were T3 or above.
There were 54 positive cases of lymph node metastases out of 102 cases (52.9%). The SUV max of the primary tumors from the lymph nodal metastasis positive group was significantly higher than that of the negative group (positive group: 15.9 Ϯ 7.0, negative group: 5.9 Ϯ 6.3, P Ͻ 0.0001). There were 1 to 8 lymph node stations, with an average of 2.1 lymph nodal metastasis stations in the lymph nodal metastasis cases.
Study on the Primary Tumors
The correlation between the SUV max of the primary tumors and the various clinicopathologic factors of the primary tumors was studied. The 4 factors of the primary tumors were as follows: (1) differentiation, (2) depth of tumor invasion, (3) lymphatic invasion, and (4) venous invasion (Table 1) .
Of the 102 primary tumors, 85 (83.3%) were detected by the preoperative PET/CT examinations. In the superficial carcinoma (T1) group that had reached to the bottom mucosal layer, a PET/CT detected 22 of 39 cases (56.4%) that were pathologically diagnosed as superficial carcinoma ( Table 1 ). All of the cases whose primary tumors were T2 or higher were detected as PET/CT-positive. Regarding the correlation between the SUV max of the primary tumors and differentiation, there was not a significant difference between the well/moderately differentiated and the poorly differentiated groups (Table 1) .
Next, the depth of tumor invasion of the primary tumors and SUV max were studied. We examined the difference between 2 groups; one was superficial carcinomas that reached to the submucosal layer, and the other was advanced cancer that invaded deeper than the muscle layer. The results showed that there was a clear and significant difference between the 2 groups (Table 1 ). When the SUV max values of the primary tumors were compared between the presence and the absence of infiltrations to lymphatic vessels and venous vessels, a significantly higher SUV max was found in the cases with the presence of vessel infiltrations, especially ones with venous infiltration (Table 1 ).
Examining Lymph Node Metastases and Various Factors
The correlation between the SUV max of the lymph nodal metastasis and 5 factors of the primary tumors was examined. The 5 factors were as follows: (1) the SUV max of the primary tumors, (2) differentiation, (3) depth of tumor invasion, (4) lymphatic invasion, and (5) venous invasion ( Table 1 ). The results regarding the correlation between the differentiation of the primary tumors and the SUV max of the lymph nodal metastasis showed that there was a significant difference in the SUV max of the lymph nodal metastasis in both the poorly differentiated and the well/moderately differentiated groups ( Table 1 ). The SUV max of the lymph nodal metastasis from the primary tumors in the poorly differentiated group was significantly higher (P ϭ 0.034). The SUV max was not affected due to the depth of tumor invasion, lymphatic invasion, or venous invasion (Table 1) . Moreover, there was no significant correlation between the SUV max of the primary tumors and that of the metastasized lymph nodes ( Fig. 2A ) (R ϭ 0.16, P ϭ 0.092). Next was an examination of the correlation between the SUV max of the lymph nodal metastasis and the tumor volume of the metastasized lymph nodes (Fig. 2B) . A significant positive correlation was found between them (R ϭ 0.62, P Ͻ 0.0001). In addition, when the proliferation of lymph nodal metastasis was determined by measuring the Ki-labeling index (Ki-LI), no significant correlation was found between the SUV max of the lymph nodal metastasis and Ki LI (Fig. 2C ) (R ϭ 0.024, P ϭ 0.80). However, after examining the correlation between the SUV max per unit area of lymph nodal metastasis (SUV max /mm 2 ) and Ki LI, the result was P ϭ 0.030 (Fig. 2D) . Therefore, a positive correlation was confirmed between them.
Examining the Diagnostic Performance of Recurrent Nerve Chain Nodes
The diagnostic accuracies of PET/CT and conventional CT scans regarding the detection capability of metastasis to the lymph nodes around recurrent nerve chains were specifically examined. The sensitivities of PET/CT and conventional CT scans were 45.7% and 68.6%, respectively (Table 2) , whereas the specificity of PET/CT was higher than that of conventional CT scans (PET/CT: 95.9%, conventional CT scan: 80.5%, Table 2 ). The better accuracy was given to PET/CT (PET/CT: 87.3%, conventional CT scan: 78.4%; P Ͻ 0.001, McNemar test; Table 2 ).
DISCUSSION
As reported in the past, it is difficult to detect and diagnose superficial cancer by PET/CT, whose utility is higher in diagnosing advanced cancers. [22] [23] [24] [25] Our study showed a significantly higher SUV max in advanced cancer compared with superficial cancer. Therefore, it can be concluded that a higher SUV max value of a primary tumor indicates a deeper invasive status. Our study also revealed that primary tumors with positive vessel invasion had a significantly higher SUV max , similar to a previous report. 8 In addition, the SUV max of primary tumors in the positive lymph nodal metastasis group had a significantly higher SUV max compared with the negative group. Therefore, it can be concluded that cases with a higher SUV max of the primary tumor tended to have a higher possibility to be accompanied with lymph nodal metastasis. On the other hand, differentiation of the primary tumors did not have a correlation with SUV max value. As Kato et al reported, 8 the SUV max of the primary tumors is influenced by the depth of tumor invasion and vascular invasion. Interestingly, a correlation was found between the differentiation of the primary tumors and the SUV max of the lymph node metastases, although the detailed mechanism is still unclear. It is not surprising that a significant positive correlation was found between the SUV max of the lymph node and the tumor volume since SUV max is generally recognized to be positively correlated with the major tumor axis of esophageal primary tumors as reported previously. 8 A hypothesis was made in our study that SUV max could indicate tumor-cell proliferation as well as tumor volume. There are reports in previous studies 26, 27 performing immunostaining using Ki-67 which reported a correlation between tumor cell proliferation and prognosis, and a correlation of SUV max using FDG PET. Our study is the first report that to show a significant positive correlation between SUV max /mm 2 and Ki LI in metastasized lymph nodes. Thus, it is necessary to take tumor volume into consideration when examining the correlation between proliferation and SUV max .
Deciding on the necessity of dissecting cervical lymph nodes is very important to perform surgery, and it is reported that this decision affects the prognosis, depending on how many metastases there are. 28 -31 Especially, thoracic esophageal cancer often develops metastasis to the lymph nodes around recurrent nerve chain. 32 A report from Shiozaki et al states that performing cervical lymph node dissection improves the prognosis for cases with lymph node positive metastasis around the recurrent nerve. 33 Ueda et al reported that they diagnose recurrent nerve chain nodes during surgery and decide to perform cervical lymph node dissection or not depending on the presence of metastasis. 34 There are some other reports on this 35 and recently the recognition of the importance of lymph node dissection has gradually been increasing around the world. 36 Some reported that the number of lymph nodes dissected affects prognosis 31, 37 ; therefore, it can be said that lymph node dissection will have an even greater importance in the future. For these reasons, the dissection of recurrent nerve chain nodes is very important clinically, and increasing the diagnostic accuracy of lymph nodal metastasis around the recurrent nerve is important as well.
Several reports have demonstrated the advantages of PET/CT, for not only the detection 38 and diagnosis of metastases, 14, 39 but also for therapeutic evaluation for chemotherapy and radiotherapy, prognostic prediction, 40, 41 and for utility regarding prognostic prediction based on the number of lymph node metastases. 42 There are also reports on finding synchronous double cancers. 43, 44 Additionally, there are reports that PET/CT has high diagnostic performance even in diagnosing postoperative recurrence. 45, 46 Other reports described that treatment strategies were changed by a PET diagnosis, and some cases avoided surgery after detecting a distant metastasis by PET. 47, 48 These facts indicate that PET/CT is becoming essential in clinical practice.
On the other hand, inflammatory regions could also collect FDG and may give a false positive diagnosis. This is an example of the limitations of PET/CT. 6,49 -51 In such cases, it is very difficult to distinguish between benignity and malignancy. Still, introducing PET/CT has brought great improvement when examining the biologic activities of tumors, evaluating therapeutic effects, and studying prognostic predictions. Our study shows the correlations between the diagnostic performance of PET/CT and tumor cell proliferation when diagnosing lymph nodal metastasis of esophageal cancer, and these findings should be meaningful for diagnosing and treating esophageal carcinoma in the future.
In conclusion, this study successfully demonstrates that there is a correlation between the proliferation of lymph nodal metastasis shown by Ki LI and SUVmax. Based on this finding, it can be considered that diagnosing lymph nodal metastasis using PET/CT can help decided the area of cervical lymph node dissection for surgery.
